Indira Maisnam discusses the current knowledge of obesity in diabetes and the effects some treatments have on weight management.
1) Why do you think that the effect of pharmacotherapy in obesity for weight loss is just satisfactory and not excellent? (0:12)
2) What are the other options that we may explore? (1:07)
3) How does the adipose tissue work in the homeostasis of body weight? (1:33)
4) Do the treatments that are currently available for diabetes effect adipose tissue? (2:25)
5) What is in the pipeline with regards to adipose tissue? (3:20)
Speaker disclosure: Indira Maisnam has nothing to disclose in relation to this video interview.
Filmed at the European Association for the Study of Diabetes (EASD) annual meeting, Berlin, Germany, 2018
Share this Video
Related Videos In Obesity
Sanjay Kalra: Research Highlights from 2021
We were delighted to speak with our editorial board member Dr Sanjay Kalra (Bharti Hospital, Karnal, India) around last year’s research highlights in the field of diabetes and obesity. Questions In the field of diabetes and obesity, what have been the most exciting research highlights of 2021? (0:32) What is your advice for health care […]
Claudia Fox, ENDO 2021: Exenatide for Weight Loss Maintenance in Adolescents
We were delighted to talk to Professor Claudia Fox (University of Minnesota, Minneapolis, MN, US) around the use of exenatide for weight loss maintenance among adolescents with severe obesity. ‘Once-Weekly Exenatide Enhances Weight Loss Maintenance in Adolescents with Severe Obesity: A Randomized, Placebo-Controlled Trial.‘ (PRESENTATION NUMBER: OR02-4) was presented at the ENDO 2021 Virtual Annual […]
Domenica M. Rubino, ENDO 2021: Findings from the STEP 4 Study
It was a pleasure to talk to Dr Domenica Rubino (Washington Center for Weight Management and Research, Arlington, VA, US) around the effect of once-weekly semaglutide on weight loss maintenance in overweight or obese adults. ‘Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4).‘ (PRESENTATION […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!